Updated 21 August 2026
Constellation Energy (NASDAQ: CEG) traded at $275.75 in the pre-market on 21 August 2026, up 1.04%, after closing at $272.92 on 20 August, down 0.46%, per stockanalysis.com. Market capitalisation is about $96.70 billion and the one-year range runs $228.63 to $412.70.
Verdict: a rare case where the company raised guidance and the stock still sits a third below its high. All 22 published analyst targets are above the current price, from $290 (+5%) to $441 (+60%) around a $347.50 (+26%) average. The bear case is not in the targets. It is in the cash flow statement.
Constellation Energy is the largest nuclear operator in the United States, it closed a transformational acquisition in January, it raised its full-year earnings guidance three weeks ago, and its shares are down about 14% over twelve months and roughly 33% below the $412.70 high they set within the past year. CEG traded at $275.75 in the pre-market on 21 August 2026, up 1.04% after a 0.46% decline the previous session, per stockanalysis.com.
That combination is unusual enough to be worth taking seriously rather than explaining away. When a business beats and raises while its equity de-rates, the market is either wrong or it is looking at a line item the earnings release does not lead with. In Constellation’s case there is a specific candidate, and it is the one most of the bullish commentary skips.
Key facts
- $275.75 – CEG pre-market price, 21 August 2026, +1.04%; previous close $272.92, -0.46%; one-year range $228.63 to $412.70 – stockanalysis.com
- -13.97% – twelve-month share price change, against a drawdown of about 33% from the annual high – stockanalysis.com
- $2.55 – Q2 2026 adjusted operating earnings per share, up from $1.91 in Q2 2025; revenue of $7.5bn rose 23% year on year but missed the $7.94bn consensus – Constellation Q2 2026 results, 6 August 2026
- $11.50-$12.50 – full-year 2026 adjusted operating EPS guidance, raised at the Q2 print from the prior $11.00-$12.00 range – Constellation Q2 2026 guidance
- ~55 GW – fleet size after the Calpine acquisition closed on 7 January 2026, supplying roughly 10% of US clean energy – company disclosure
- 40 TWh at a 93% capacity factor – Q2 nuclear output, across six refuelling outages averaging 23 days, about 40% better than the industry average – Constellation Q2 2026 results
- ~920 MW – long-term nuclear power purchase agreements signed in the quarter with investment-grade customers, averaging 18.5 years in duration – Constellation Q2 2026 results
- $295m – trailing twelve-month free cash flow, against $3.47bn of net income and $24.70bn of total debt – stockanalysis.com
The quarter was good, and the guidance went up
Constellation reported second-quarter adjusted operating earnings of $2.55 a share on 6 August 2026, against $1.91 in the same quarter of 2025. Management attributed the improvement to the Calpine contribution, higher capacity revenue in PJM, portfolio optimisation and higher realised customer margins – a broad-based list rather than a single one-off.
Crucially, the company then raised full-year 2026 adjusted operating EPS guidance to $11.50 to $12.50, up from the prior $11.00 to $12.00. At the $275.75 pre-market price, the midpoint of that range puts the stock on roughly 23 times this year’s guided earnings, which lines up with the 22.24x forward multiple reported by stockanalysis.com.
The operating record supports it. The nuclear fleet generated 40 TWh in the quarter at a 93% capacity factor, completing six refuelling outages at an average of 23 days – roughly 40% faster than the industry norm. Outage duration is not a glamorous metric, but for a nuclear operator it is close to the whole game: every day a reactor is offline is a day of lost megawatt-hours against a largely fixed cost base. Constellation runs its fleet unusually well, and that is a durable rather than cyclical advantage.
The contracting story is real, and it is long-dated
The strategic case rests on converting baseload nuclear output into multi-decade contracts with creditworthy technology buyers, and the quarter delivered: approximately 920 MW of new long-term nuclear PPAs with investment-grade customers, at an average duration of 18.5 years.
That sits on top of an existing book that includes a 20-year, 1,121 MW agreement with Meta, the Microsoft-backed Crane restart, and a deal with CyrusOne. The economic logic is straightforward. A merchant generator sells power at whatever the market clears at; a generator with an 18-year contract at a fixed escalating price has converted a commodity stream into something closer to an annuity. That should, in theory, earn a higher multiple rather than a lower one.
It also explains why Constellation and a merchant peer such as Vistra deserve to be analysed separately even though both are routinely bundled into the same AI-power trade. Vistra’s problem this year has been soft ERCOT forward prices hitting an unhedged merchant margin. Constellation’s contracted nuclear book is largely insulated from that specific risk. The two stocks are down for different reasons, and only one of them is a power-price story.
Where the bear case actually lives: cash conversion and the Calpine balance sheet
Here is the line the bullish write-ups tend to skip. Constellation generated $295 million of free cash flow on a trailing twelve-month basis, against $3.47 billion of net income. That is a conversion rate of under 10%, and it sits alongside $24.70 billion of total debt, $697 million of cash and a debt-to-equity ratio of 0.76 following the Calpine close.
There are entirely reasonable explanations. Integrating a fleet that roughly doubled the company’s generating capacity consumes working capital; nuclear uprates, the Crane restart and growth capital expenditure are cash out today against contracted revenue that arrives over eighteen-year horizons; and trailing twelve-month figures straddle the January acquisition, so the comparison is not clean. None of that is evidence of a problem. But it does mean that an investor buying CEG at 23 times guided earnings is buying an accounting earnings stream, not a cash one, and is trusting that the capital cycle inverts on schedule.
That is the honest bear case, and it is a balance-sheet case rather than a demand case. The dividend tells the same story from another angle: $1.71 a share annually, a 0.63% yield on a 16.52% payout ratio. Constellation is retaining almost everything it earns, which is the correct decision for a company building into a demand boom, but it removes the cash-return floor that usually supports a utility valuation during a drawdown.
12-month analyst targets: low $290, mid $347.50, high $441
A note on how this table is framed, because it matters. Every one of the 22 published analyst targets on Constellation currently sits above the traded price. There is no bearish street target to report, so labelling the lowest one a “bear case” would be misleading – the low end of the range still implies upside. What follows is the published distribution, not a scenario forecast.
| Case | 12-month level | vs $275.75 | Anchor |
|---|---|---|---|
| Low | $290 | +5.2% | The lowest published target of the 22 analysts covering CEG, matching Mizuho’s Anthony Crowdell, who carries a Hold rating with a $290 target dated 12 August (stockanalysis.com). Even the most cautious house on the street sees a modest gain. |
| Mid | $347.50 | +26.0% | The consensus average across 22 analysts, with a Buy consensus rating. Consistent with 2026 guidance landing in the raised $11.50-$12.50 band and the multiple holding near current levels. |
| High | $441 | +59.9% | The highest published target (stockanalysis.com). Requires a re-rating back through the $412.70 annual high, which in practice means the market paying an annuity multiple for the contracted nuclear book rather than a merchant one. |
And the downside the targets do not show. Since the street offers no bearish anchor, the useful reference points are the stock’s own recent history. The one-year low of $228.63 sits 17.1% below the current price, and CEG has already fallen 33% from its high once inside the last twelve months, so a move of that size plainly is not hypothetical. A realistic downside path would combine slower cash conversion than the Calpine integration plan assumes, a pause in new PPA signings, and multiple compression toward the regulated-utility band. Readers should weight that scenario themselves; nobody on the sell side is currently publishing it.
Recent revisions have been moving upward. Morgan Stanley’s David Arcaro published $364 on 21 August, Exane BNP Paribas’ Moses Sutton $374 on 19 August and DBS’ Pei Hwa Ho $350 on 18 August, with Bernstein at $296 on 17 August. Four of the five most recent updates sit at or above the consensus average, and the dissenting voice, Mizuho, is a Hold rather than a Sell.
Quick Take
The bull case in one line: the largest US nuclear operator raised guidance, runs its fleet 40% better than the industry on outage time, and is converting baseload output into 18-year contracts with investment-grade technology buyers, while trading a third below its high.
The bear case in one line: $295m of trailing free cash flow against $3.47bn of net income and $24.70bn of debt means the earnings the multiple is applied to are not yet arriving as cash, and a 0.63% yield offers no support if that persists.
What decides it: cash conversion over the next two or three quarters as Calpine integration capital rolls off, and the pace of new long-term PPA signings. Watch the cash flow statement, not the EPS headline.
How CEG compares with the rest of the power complex
Constellation sits in the middle of a group that has stopped trading as one theme. Cameco is up about 26% over twelve months on the fuel side of the AI-power trade. Vistra is down about 28% on merchant power price compression. Constellation, at about -14%, is the least bad of the generators and the only one of the three whose earnings guidance moved up this reporting season. Smaller reactor developers such as NuScale are a different proposition again, selling into a market that has not opened yet.
The dispersion across the sector is the point. Anyone treating “AI needs electricity” as a single trade is buying four unrelated risk profiles under one label: fuel scarcity, merchant spark spreads, contracted baseload, and pre-revenue technology. Constellation is the contracted-baseload version, and it should be judged on contract conversion and cash generation rather than on power price forecasts.
Frequently asked questions
What is Constellation Energy’s 2026 earnings guidance?
Adjusted operating earnings of $11.50 to $12.50 per share, raised at the Q2 2026 results on 6 August 2026 from a prior range of $11.00 to $12.00. Second-quarter adjusted operating EPS was $2.55, against $1.91 a year earlier.
What is the analyst price target for CEG?
The consensus average is $347.50 across 22 analysts with a Buy consensus rating, per stockanalysis.com as at 21 August 2026. The published range runs from $290 at the low to $441 at the high. Notably, every target in that range sits above the current $275.75 price.
Why is CEG stock down if the AI power story is intact?
The share price is about 14% lower over twelve months and roughly 33% below its annual high, while earnings guidance went up. The most plausible explanation is cash conversion rather than demand: trailing free cash flow of $295m against $3.47bn of net income reflects the capital being absorbed by Calpine integration, nuclear uprates and the Crane restart. The market is discounting the timing of cash, not the existence of demand.
How big is Constellation after the Calpine acquisition?
The acquisition closed on 7 January 2026 and took the fleet to roughly 55 GW, supplying about 10% of US clean energy. It also added $24.70bn of total debt to the balance sheet, with a debt-to-equity ratio of 0.76.
Who are Constellation’s data-centre customers?
The disclosed book includes a 20-year, 1,121 MW nuclear agreement with Meta, the Microsoft-backed restart of the Crane Clean Energy Center, and an agreement with CyrusOne. In Q2 2026 the company added roughly 920 MW of new long-term nuclear PPAs with investment-grade counterparties at an average duration of 18.5 years.
Does Constellation pay a dividend?
Yes, $1.71 per share annually, a yield of about 0.63% at the current price, on a payout ratio of 16.52%. The company retains the large majority of earnings to fund growth.
Is CEG expensive at these levels?
It trades on about 22.24x forward earnings and 26.43x trailing, with an EV/EBITDA of 15.18x on an enterprise value of $120.70bn. That is a premium to the merchant power group and a discount to where CEG itself traded a year ago. Whether it is expensive depends on whether the contracted nuclear book is valued as an annuity or as commodity generation.
Price and valuation data in this article was verified on 21 August 2026 from stockanalysis.com; operating figures and guidance are from Constellation Energy’s Q2 2026 results of 6 August 2026. Prices move; check a live quote before acting on anything here.
This article is for information only. It is not investment advice, and it is not a recommendation to buy or sell any security. FinanceFeeds does not hold positions in the companies mentioned. Do your own research and consider speaking to a regulated financial adviser before making investment decisions.
